Study Shows Health Benefits of Walnuts
the ONA take:
According to a new study published in the Journal of Medicinal Food, researchers at University of California, Davis, in Davis, California, have found that consuming a diet rich in whole walnuts or walnut oil decreased the rate of prostate cancer growth, reduced cholesterol, and increased insulin sensitivity in mice.
In addition, the walnut-rich diet reduced insulin-like growth factor 1 (IGF-1), which has been shown to cause prostate and breast cancer. For the study, researchers sought to investigate which part of walnuts cause the health benefits that have been identified in previous studies. Researchers fed mice either whole walnuts, walnut oil, or a mixture of walnut-like fat for 18 weeks.
They found that the walnuts and walnut oil, but not the fatty acid mixture, caused health benefits like decreased prostate cancer growth and decreased cholesterol. The findings suggest that the meat and oil of walnuts cause health benefits, but not the omega-3 fatty acids of the walnut; however, it could also be a combination of the three components. The study also found that the health benefits of walnuts are not magnesium, selenium, or zinc.
The researchers note that although this study does not prove that the benefits of walnuts will translate from mice to humans, it may be beneficial to incorporate walnuts into a diet.
Diet rich in whole walnuts or walnut oil decreased the rate of prostate cancer growth.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|